Divis Laboratories Ltd | DIVI - Operating Profit


Divis Laboratories Ltd reported INR14.24B in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
Alaunos Therapeutics USD -952K 60K Jun/2026
Aurobindo Pharma INR 16.25B 2.3B Sep/2026
Avita Medical AUD -6.86M 3.55M Jun/2026
Dianthus Therapeutics USD -61.48M 14.95M Jun/2026
Divis Laboratories Ltd INR 14.24B 2.95B Sep/2026
Ionis Pharmaceuticals USD -130M 27.71M Sep/2026
IQVIA Holdings USD 608M 1.99B Sep/2026
Lupin INR 14.72B 5.39B Sep/2026
Moderna USD 130M 945M Sep/2026
Organon & Co USD 377M 54M Sep/2026
Revvity USD 124.63M 1.51M Sep/2026
Tectonic Therapeutic USD -24.22M 3.08M Jun/2026
Tilray USD -20.01M 9.34M Sep/2025
Viatris USD 255.5M 181.8M Sep/2026
Xeris Pharmaceuticals USD 5.17M 2.74M Jun/2026